New approaches in HIV eradication research
- PMID: 22001946
- DOI: 10.1097/QCO.0b013e32834cfb2d
New approaches in HIV eradication research
Abstract
Purpose of review: Despite the proven efficacy of highly active antiretroviral therapy in reducing mortality and morbidity of HIV infection, longer-term strategies are less well defined and there is renewed interest in HIV eradication. This review will describe the major obstacles that need to be overcome and the key new advances and strategies designed to achieve an HIV cure.
Recent findings: Characterization of the HIV viral reservoir over the past few years has led to a better understanding of which approaches might successfully lead to eradication. A number of approaches such as histone modification, immunotoxins, gene therapy and gene knockout strategies have resulted and have been explored initially in vitro. There has been progression from both laboratory and animal model studies, and clinical trials are now underway using new approaches such as histone deacetylase inhibitors and zinc finger nucleases.
Summary: Although there is currently no cure for HIV infection, there has been a resurgence of interest in the field with the development of a number of potential new approaches, some of which have entered clinical trials.
Similar articles
-
HIV cure and eradication: how will we get from the laboratory to effective clinical trials?AIDS. 2011 Apr 24;25(7):885-97. doi: 10.1097/QAD.0b013e3283467041. AIDS. 2011. PMID: 21422987 Review.
-
HDAC inhibitors in HIV.Immunol Cell Biol. 2012 Jan;90(1):47-54. doi: 10.1038/icb.2011.95. Epub 2011 Nov 15. Immunol Cell Biol. 2012. PMID: 22083528 Review.
-
Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy.Proc Natl Acad Sci U S A. 2014 May 13;111(19):7078-83. doi: 10.1073/pnas.1402873111. Epub 2014 Mar 31. Proc Natl Acad Sci U S A. 2014. PMID: 24706775 Free PMC article.
-
Finding a cure for HIV: will it ever be achievable?J Int AIDS Soc. 2011 Jan 24;14:4. doi: 10.1186/1758-2652-14-4. J Int AIDS Soc. 2011. PMID: 21255462 Free PMC article.
-
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.J Virol. 2015 Oct;89(20):10176-89. doi: 10.1128/JVI.01484-15. Epub 2015 Jul 29. J Virol. 2015. PMID: 26223643 Free PMC article. Clinical Trial.
Cited by
-
Controlling the HIV/AIDS epidemic: current status and global challenges.Front Immunol. 2012 Aug 14;3:250. doi: 10.3389/fimmu.2012.00250. eCollection 2012. Front Immunol. 2012. PMID: 22912636 Free PMC article.
-
The Use of Ultra-Sensitive Molecular Assays in HIV Cure-Related Research.J AIDS Clin Res. 2013 May 27;Suppl 6:002. doi: 10.4172/2155-6113.S6-002. J AIDS Clin Res. 2013. PMID: 25328815 Free PMC article.
-
Therapeutic vaccines in HBV: lessons from HCV.Med Microbiol Immunol. 2015 Feb;204(1):79-86. doi: 10.1007/s00430-014-0376-8. Epub 2015 Jan 9. Med Microbiol Immunol. 2015. PMID: 25573348 Free PMC article. Review.
-
Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly.PLoS One. 2013 Jul 16;8(7):e68669. doi: 10.1371/journal.pone.0068669. Print 2013. PLoS One. 2013. PMID: 23874714 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous